These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2781235)

  • 41. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impairment of bile secretion induced by exhaustive exercise in the rat. Protective effects of S-adenosyl-L-methionine.
    Villa JG; Almar MM; Collado PS; Llamazares E; González-Gallego J
    Int J Sports Med; 1993 May; 14(4):179-84. PubMed ID: 8325715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic and blood lead levels in patients with chronic liver disease.
    Castilla L; Castro M; Grilo A; Guerrero P; Lopez-Artiguez M; Soria ML; Martinez-Parra D
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):243-9. PubMed ID: 7743306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol.
    Rua RM; Ojeda ML; Nogales F; Rubio JM; Romero-Gómez M; Funuyet J; Murillo ML; Carreras O
    Life Sci; 2014 Jan; 94(2):158-63. PubMed ID: 24157457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methionine adenosyltransferase and S-adenosylmethionine in alcoholic liver disease.
    Lu SC; Martínez-Chantar ML; Mato JM
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S61-4. PubMed ID: 16958675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis.
    Guo T; Chang L; Xiao Y; Liu Q
    PLoS One; 2015; 10(3):e0122124. PubMed ID: 25774783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased hepatic glutathione in chronic alcoholic patients.
    Jewell SA; Di Monte D; Gentile A; Guglielmi A; Altomare E; Albano O
    J Hepatol; 1986; 3(1):1-6. PubMed ID: 3745878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. S-adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured rats.
    Deulofeu R; Parés A; Rubio M; Gassó M; Román J; Giménez A; Varela-Moreiras G; Caballeria J; Ballesta AM; Mato JM; Rodés J
    Clin Sci (Lond); 2000 Oct; 99(4):315-20. PubMed ID: 10995597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review article: S-adenosyl-L-methionine--a new therapeutic agent in liver disease?
    Osman E; Owen JS; Burroughs AK
    Aliment Pharmacol Ther; 1993 Feb; 7(1):21-8. PubMed ID: 8439634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intestinal absorption of S-adenosyl-L-methionine.
    Stramentinoli G; Gualano M; Galli-Kienle M
    J Pharmacol Exp Ther; 1979 Jun; 209(3):323-6. PubMed ID: 439007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease.
    Kaye GL; Blake JC; Burroughs AK
    Drugs; 1990; 40 Suppl 3():124-8. PubMed ID: 2081477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of S-adenosylmethionine on clinical pathology and redox potential in the red blood cell, liver, and bile of clinically normal cats.
    Center SA; Randolph JF; Warner KL; McCabe-McClelland J; Foureman P; Hoffmann WE; Erb HN
    J Vet Intern Med; 2005; 19(3):303-14. PubMed ID: 15954543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [S-adenosyl-L-methionine (SAMe) and its use in hepatology].
    Frezza M; Terpin MM; Peri A
    Minerva Gastroenterol Dietol; 1992; 38(3):145-51. PubMed ID: 1299337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.
    Friedel HA; Goa KL; Benfield P
    Drugs; 1989 Sep; 38(3):389-416. PubMed ID: 2680435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
    Martínez-Uña M; Varela-Rey M; Mestre D; Fernández-Ares L; Fresnedo O; Fernandez-Ramos D; Gutiérrez-de Juan V; Martin-Guerrero I; García-Orad A; Luka Z; Wagner C; Lu SC; García-Monzón C; Finnell RH; Aurrekoetxea I; Buqué X; Martínez-Chantar ML; Mato JM; Aspichueta P
    J Hepatol; 2015 Mar; 62(3):673-81. PubMed ID: 25457203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. S-adenosyl-L-methionine and the liver.
    Ortiz P; Moreno J; Puerta JL; Mato JM
    Ital J Gastroenterol; 1993 Apr; 25(3):135-7. PubMed ID: 8507890
    [No Abstract]   [Full Text] [Related]  

  • 58. B-Vitamin dependent methionine metabolism and alcoholic liver disease.
    Halsted CH
    Clin Chem Lab Med; 2013 Mar; 51(3):457-65. PubMed ID: 23096111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Protective effects of bicyclol on alcohol-induced liver damage in mice].
    Mo CL; Li Y; Li Y
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3409-13. PubMed ID: 16409862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Behaviour of ammonemia during treatment of chronic/hyperammonemic hepatopathy with S-adenosyl-L-methionine].
    De Caprio M; Carbone G; Cerotto GM; Corbosiero L; Vitale A
    Clin Ter; 1980 Mar; 92(6):587-602. PubMed ID: 7460488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.